| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.0003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |